Association of FGFR3 and MDM2 Gene Nucleotide Polymorphisms with Bone Tumors

[1]  Ming Yang,et al.  The functional MDM2 T309G genetic variant but not P53 Arg72Pro polymorphism is associated with risk of sarcomas: a meta-analysis , 2012, Journal of Cancer Research and Clinical Oncology.

[2]  R. Hayes,et al.  A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma , 2011, BMC Cancer.

[3]  H. Sasaki,et al.  Tumour formation by single fibroblast growth factor receptor 3-positive rhabdomyosarcoma-initiating cells , 2009, British Journal of Cancer.

[4]  Xavier Estivill,et al.  SNPassoc: an R package to perform whole genome association studies , 2007, Bioinform..

[5]  Ingo Mierswa,et al.  YALE: rapid prototyping for complex data mining tasks , 2006, KDD '06.

[6]  J. Varley.  Germline TP53 mutations and Li‐Fraumeni syndrome , 2003, Human mutation.

[7]  Jun-Hyeog Jang.  Identification and characterization of soluble isoform of fibroblast growth factor receptor 3 in human SaOS-2 osteosarcoma cells. , 2002, Biochemical and biophysical research communications.

[8]  A. Cleton-Jansen,et al.  Up-Regulation of PTHrP and Bcl-2 Expression Characterizes the Progression of Osteochondroma towards Peripheral Chondrosarcoma and Is a Late Event in Central Chondrosarcoma , 2000, Laboratory Investigation.

[9]  J. Ross Quinlan,et al.  Induction of Decision Trees , 1986, Machine Learning.

[10]  Takuji Tanaka,et al.  An evaluation of the integration of non-traditional learning tools into a community based breast and cervical cancer education program: The witness project of Buffalo , 2003, BMC Cancer.

[11]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[12]  C. Cockerell,et al.  Evaluation of the tumorigenic and angiogenic potential of human fibroblast growth factor FGF3 in nude mice , 1998, Journal of Cancer Research and Clinical Oncology.